The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study)

Aim      To evaluate the prevalence of residual symptoms in patients hospitalized for novel coronavirus infection at 8 months after discharge and the severity of such symptoms depending on demographic characteristics, concurrent diseases, and specific features of the acute period of COVID-19.

Material and methods  This study included the patients who were managed for novel coronavirus infection in a COVID-19 hospital and provided their consent to participate in the study (98 patients). At 8 months after discharge from the hospital, a structured telephone interview was performed.

Results Only 40 % of patients treated for COVID-19 did not have any complaints at 8 months after discharge from the hospital. The most frequent complaints in the long term were fatigue (30.5 %), weakness (28.4 %), shortness of breath (23.2 %), arthralgia (22.1 %), myalgia (17.9 %), and anosmia (15.8 %). The background of chronic diseases and obesity, percentage of lung damage according to CT data, and the requirement for oxygen support during the acute period in our sample were not related with the presence of symptoms in the long term. The presence and severity of symptoms during the long term were not determined by the clinical condition, volume of lung damage, or requirement for oxygen support but were related with the gender and severity of inflammation upon admission.

Conclusion      Independent predictors for persistence of symptoms in the patient sample with severe novel coronavirus infection during the long term included chest and joint pain during the stay in the hospital, female gender, and increased levels of C-reactive protein upon admission.

1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. DOI: 10.1001/jama.2020.2648

2. Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y и др. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection. 2021;27(1):89–95. DOI: 10.1016/j.cmi.2020.09.023

3. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 PostAcute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–5. DOI: 10.1001/jama.2020.12603

4. Bowles KH, McDonald M, Barrón Y, Kennedy E, O’Connor M, Mikkelsen M. Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients. Annals of Internal Medicine. 2021;174(3):316–25. DOI: 10.7326/M20-5206

5. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L и др. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross‐sectional evaluation. Journal of Medical Virology. 2021;93(2):1013–22. DOI: 10.1002/jmv.26368

6. Mareev V.Yu., Begrambekova Yu.L., Mareev Yu.V. How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID). Kardiologiia. 2020;60(11):35–41. DOI: 10.18087/cardio.2020.11.n1439

7. Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR и др. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open. 2021;4(2):e210830. DOI: 10.1001/jamanetworkopen.2021.0830

8. Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S и др. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325(19):2015–6. DOI: 10.1001/jama.2021.5612

9. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS и др. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396–8. DOI: 10.1136/thoraxjnl-2020-215818

10. Petersen EL, Goßling A, Adam G, Aepfelbacher M, Behrendt C-A, Cavus E и др. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. European Heart Journal. 2022;43(11):1124–37. DOI: 10.1093/eurheartj/ehab914

11. Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC и др. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Research. 2020;6(4):00542–2020. DOI: 10.1183/23120541.00542-2020

12. Nehme M, Braillard O, Alcoba G, Aebischer Perone S, Courvoisier D, Chappuis F и др. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Annals of Internal Medicine. 2021;174(5):723–5. DOI: 10.7326/M20-5926

13. Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A и др. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine. 2022;10(8):761–75. DOI: 10.1016/S2213-2600(22)00127-8